Show simple item record

dc.contributor.authorAdhiambo, Christine
dc.date.accessioned2013-05-24T08:59:15Z
dc.date.available2013-05-24T08:59:15Z
dc.date.issued1995
dc.identifier.citationMSc.en
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/25273
dc.descriptionDegree of Master of Scienceen
dc.description.abstractVisceral leishmaniasis is a severe systemic human disease which is always fatal if left untreated. The treatment is however expensive, painful and has unpleasant side effects as repeated courses or a change of drugs is often required. Treatment failure is also becoming a common problem in endemic areas such as Kenya. With curative treatment proving unsatisfactory, effective alternative means of control of infection such as vaccination is necessary. The vervet monkey has been shown to be susceptible to Leishmania donovani infection and thus provides a good non-human primate model for use in vaccine development studies. The following study was undertaken to determine the nature of humoral and cellular immune response following vaccination with merthiolate killed Leishmania donovani promastigotes using neuraminidase and galactose , oxidase (NAGO) as adjuvant. Twelve vervet monkeys were used in this study. The animals were divided into 4 groups of 3 animals each. Each animal received 3 intradermal injections at 2 weeks intervals with one of the following; adjuvant plus promastigotes, promastigotes alone, adjuvant alone or PBS. Results from ELISA for the presence of anti-promastigote antibody revealed that there was production of IgG in the animals vaccinated with adjuvant plus promastigotes and those vaccinated with promastigotes alone though the IgG levels were low. The absorbance at 1:125 serum dilution was 0.324 for the adjuvant plus pro mastigote group, 0.410 for the promastigote group, 0.136 for the adjuvant group, 0.145 for the saline group and 0.954 for an infected animal used as a positive control. Western blot analysis showed that the sera from the animals vaccinated with adjuvant plus promastigotes and those vaccinated with promastigotes alone, recognized numerous Leishmania donovani promastigote antigens of molecular weight 18.5-106 KDa. There was also antibody cross-reactivity with Leishmania major promastigote antigens. High variability was observed in the pattern of antigen recognition within and among these two groups. Peripheral blood lymphocytes (PBL) from all the animal groups showed a good proliferative response upon stimulation with Con A with a stimulation index (S.I) ranging from 72-137. In addition PBL from the animals vaccinated with adjuvant plus promastigotes and those vaccinated with promastigotes alone also showed a good proliferative response upon stimulation with Leishmania donovani (S.I 10.62 and 5.62) respectively and Leishmania major promastigote antigens (S.I 4.87 and 3.87) respectively. The response to the homologous species (l:eishmania donovani) was notably higher. There was production of detectable levels of IFN-y (29-31 IU/ml) after in vitro stimulation ofPB~ with Con A in all the animal groups. There was lower/no IFN-y production after in vitro stimulation ofPBL with leishmanial antigen. Low levels of IL-4 and IL-2 were detected after in vitro stimulation of PBL with either Con A or leishmania! antigen il.J all the animal groups . There was an increase in levels of circulating CD16+, CD8+ and CD45RO+ cells in animals vaccinated with adjuvant plus antigen or with antigen alone. There was a higher increase. when the adjuvant was included vaccination . There wasno significant increase in all these cells in the groups of animals vaccinated with adjuvant or saline alone. The animals vaccinated with adjuvant plus promastigotes and those vaccinated with promastigotes alone gave a positive but weak DTE response. The skin induration was 8.62mm ± 1.02 and 7.88mm ± 1.00 respectively. The skin induration for the animals vaccinated with adjuvant alone was 5.5mm ± 0.15. The animals vaccinated with saline alone gave a DTE response of less than 5mm. From the above results it was apparent that the adjuvant improved the immunogenicity of the killed Leishmania donovani pro mastigote vaccine. However the full extent of the protection could have been realised by challenging the animals with virulent Leishmania donovani promastigote. Animal challenge experiments are underway in a separate study and have not been included in this thesisen
dc.language.isoenen
dc.titleCharacterisation of immune responses in vervet monkeys (Cercopithecus Aethiops) following vaccination with leishmania donovani antigenen
dc.typeThesisen
local.publisherSchool of Biological Sciences, University of Nairobien


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record